Skip to Main Content

Advertisement

Skip Nav Destination

Allogeneic Transplant Plus NK Cells in High-Risk Myeloma

December 30, 2021

Dr. Shah discusses natural killer cells for myeloma – a cellular therapy that “kills” without causing graft-versus-host disease.

Advertisement

Connect with us:

CURRENT ISSUE
Mid-November 2022

Advertisement

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement